2022
DOI: 10.2147/ijgm.s352859
|View full text |Cite
|
Sign up to set email alerts
|

A Novel Glutamine Metabolism-Related Gene Signature in Prognostic Prediction of Osteosarcoma

Abstract: Purpose Metabolic reprogramming, as one of the hallmarks of cancer, shows promising translational potential for cancer diagnosis, treatment and prognostic prediction. This study aims to construct and validate a prognostic prediction model for osteosarcoma based on glutamine metabolism-related genes. Materials and Methods A group of glutamine metabolism-related genes was identified from a public database and intersected with a list of osteosarcoma survival-related genes,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 41 publications
0
1
0
Order By: Relevance
“…In osteosarcoma, Wan et al created a risk model for osteosarcoma using glutamine metabolism-related genes. While immune microenvironment analysis was still waiting to be verified ( Wan et al, 2022 ), Jiang et al investigated genes related to branched-chain amino acid (BCAA) metabolism in pancreatic cancer. They constructed the risk model by the univariable Cox regression and LASSO analysis while lacking definite specificity and sensitivity tests and relatively convincing immune cell analysis ( Jiang et al, 2022 ).…”
Section: Discussionmentioning
confidence: 99%
“…In osteosarcoma, Wan et al created a risk model for osteosarcoma using glutamine metabolism-related genes. While immune microenvironment analysis was still waiting to be verified ( Wan et al, 2022 ), Jiang et al investigated genes related to branched-chain amino acid (BCAA) metabolism in pancreatic cancer. They constructed the risk model by the univariable Cox regression and LASSO analysis while lacking definite specificity and sensitivity tests and relatively convincing immune cell analysis ( Jiang et al, 2022 ).…”
Section: Discussionmentioning
confidence: 99%